Ippolito Giuseppe, Palazzo F Fausto, Sebag Frederic, Henry Jean François
Department of Endocrine Surgery, La Timone Hospital, Marseille, France.
Surgery. 2007 Dec;142(6):819-22; discussion 822.e1. doi: 10.1016/j.surg.2007.08.010.
External radiation is associated with a risk of hyperparathyroidism. We reviewed the outcomes after operation for radiation-induced hyperparathyroidism (R-HPT).
We conducted a retrospective review of all patients who had operative therapy for R-HPT from 1980 to 2003 in our department with a minimum of 3 years of follow-up after operative therapy.
Between 1980 and 2003, 1932 patients underwent parathyroidectomy for primary hyperparathyroidism. Thirty-seven (1.92%) patients had a history of neck irradiation. Thirty-two patients underwent a bilateral exploration (BE), and 5 patients had a focused approach (FA). Thirty-five patients presented with single gland disease, and 2 patients had multiple gland disease. In the BE group, 26 patients remained cured biochemically after a median follow-up of 10.3 years (range, 3-21 years), and 6 patients had recurrence after a median of 13.2 years (range, 7-22 years). In the FA group, all 5 patients remained cured biochemically; however, the median follow-up remained shorter (6.4 years; range, 3-8 years).
In R-HPT, the incidence of multiple gland disease at the time of initial operation was comparable with sporadic HPT. In the absence of thyroid disease, an FA may be proposed for R-HPT. Metachronous pathologic glands may develop several years after successful parathyroidectomy in R-HPT. Hence, lifelong follow-up of these patients is essential.
外照射与甲状旁腺功能亢进风险相关。我们回顾了放射性甲状旁腺功能亢进症(R-HPT)手术后的结果。
我们对1980年至2003年在我科接受R-HPT手术治疗且术后至少随访3年的所有患者进行了回顾性研究。
1980年至2003年间,1932例患者因原发性甲状旁腺功能亢进接受了甲状旁腺切除术。37例(1.92%)患者有颈部放疗史。32例患者接受了双侧探查(BE),5例患者采用了聚焦手术(FA)。35例患者为单发性腺体疾病,2例患者为多发性腺体疾病。在BE组中,26例患者在中位随访10.3年(范围3-21年)后生化指标保持治愈,6例患者在中位13.2年(范围7-22年)后复发。在FA组中,所有5例患者生化指标均保持治愈;然而,中位随访时间较短(6.4年;范围3-8年)。
在R-HPT中,初次手术时多发性腺体疾病的发生率与散发性甲状旁腺功能亢进症相当。在无甲状腺疾病的情况下,对于R-HPT可考虑采用FA。在R-HPT中,成功进行甲状旁腺切除术后数年可能会出现异时性病理腺体。因此,对这些患者进行终身随访至关重要。